Literature DB >> 9870074

Anti-inflammatory effects of interleukin-4, interleukin-10, and transforming growth factor-beta on human placental cells in vitro.

V J Goodwin1, T A Sato, M D Mitchell, J A Keelan.   

Abstract

PROBLEM: To determine the effects of anti-inflammatory cytokines on the production of inflammatory mediators by placental cells. METHOD OF STUDY: Cells from term human placentas were isolated and cultured in vitro in the presence of anti-inflammatory cytokines interleukin (IL)-4, IL-10, and transforming growth factor (TGF)-beta. Their effects on the production of IL-8 and prostaglandin E2 (PGE2) were investigated under basal conditions and after stimulation with IL-1 beta and tumor necrosis factor (TNF)-alpha.
RESULTS: Both IL-10 and IL-4 inhibited IL-1 beta- and TNF-alpha-induced PGE2 production but had no significant effects on the production of PGE2 under basal conditions. TGF-beta 1 was without effect in stimulated cells, whereas under basal conditions TGF-beta 1 stimulated PGE2 production. Similar trends were seen for IL-8 production, with the exceptions that TGF-beta 1 decreased the TNF-alpha-induced production and IL-4 decreased basal IL-8 production.
CONCLUSIONS: The anti-inflammatory effects shown by IL-4, IL-10, and (to lesser extent) TGF-beta may play a role in ameliorating the potentially harmful effects of pro-inflammatory mediators in the feto-placental unit.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9870074     DOI: 10.1111/j.1600-0897.1998.tb00060.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  8 in total

1.  Interleukin-7 permits Th1/Tc1 maturation and promotes ex vivo expansion of cord blood T cells: a critical step toward adoptive immunotherapy after cord blood transplantation.

Authors:  Craig C Davis; Luciana C Marti; Gregory D Sempowski; Durairaj A Jeyaraj; Paul Szabolcs
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

2.  Ex vivo expansion and Th1/Tc1 maturation of umbilical cord blood T cells by CD3/CD28 costimulation.

Authors:  Melissa A Mazur; Craig C Davis; Paul Szabolcs
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

3.  Elevation of transforming growth factor-beta1 is associated with recurrent miscarriage.

Authors:  M S Ogasawara; K Aoki; T Aoyama; K Katano; Y Iinuma; Y Ozaki; K Suzumori
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

4.  Lower genital tract inflammatory milieu and the risk of subsequent preterm birth: an exploratory factor analysis.

Authors:  Hyagriv N Simhan; Lisa M Bodnar; Kevin H Kim
Journal:  Paediatr Perinat Epidemiol       Date:  2011-03-21       Impact factor: 3.980

5.  The anti-inflammatory limb of the immune response in preterm labor, intra-amniotic infection/inflammation, and spontaneous parturition at term: a role for interleukin-10.

Authors:  Francesca Gotsch; Roberto Romero; Juan Pedro Kusanovic; Offer Erez; Jimmy Espinoza; Chong Jai Kim; Edi Vaisbuch; Nandor Gabor Than; Shali Mazaki-Tovi; Tinnakorn Chaiworapongsa; Moshe Mazor; Bo Hyun Yoon; Samuel Edwin; Ricardo Gomez; Pooja Mittal; Sonia S Hassan; Surendra Sharma
Journal:  J Matern Fetal Neonatal Med       Date:  2008-08

Review 6.  The Th1:th2 dichotomy of pregnancy and preterm labour.

Authors:  Lynne Sykes; David A MacIntyre; Xiao J Yap; Tiong Ghee Teoh; Phillip R Bennett
Journal:  Mediators Inflamm       Date:  2012-06-07       Impact factor: 4.711

Review 7.  Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia.

Authors:  Corinne Rusterholz; Sinuhe Hahn; Wolfgang Holzgreve
Journal:  Semin Immunopathol       Date:  2007-06       Impact factor: 11.759

8.  The Role of Epithelial to Mesenchymal Transition in Human Amniotic Membrane Rupture.

Authors:  Carla Janzen; Suvajit Sen; Margarida Y Y Lei; Marina Gagliardi de Assumpcao; John Challis; Gautam Chaudhuri
Journal:  J Clin Endocrinol Metab       Date:  2017-04-01       Impact factor: 5.958

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.